NCT02131350View on ClinicalTrials.gov

Combination Treatment of Intravitreal Ranibizumab, Focal/Grid Laser and Panretinal Photocoagulation in Patients With Diabetic Macula Edema

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2018

Conditions
Diabetic Macula Edema
Interventions
PROCEDURE

Photocoagulation

Photocoagulation include focal/grid laser and/or panretinal photocoagulation

DRUG

Ranibizumab

Trial Locations (1)

3908621

Department ou Ophthalmology Shinshu University School of Medicine, Matsumoto

All Listed Sponsors
lead

Shinshu University

OTHER

NCT02131350 - Combination Treatment of Intravitreal Ranibizumab, Focal/Grid Laser and Panretinal Photocoagulation in Patients With Diabetic Macula Edema | Biotech Hunter | Biotech Hunter